New horizons in early stage COPD - Improving knowledge, detection and treatment

Respiratory Medicine

Volumn 105, Issue 11, 2011, Pages 1576-1587

  Decramer, Marc ^a   Miravitlles, Marc ^b   Price, David ^c   Román Rodríguez, Miguel ^d   Llor, Carl ^e   Welte, Tobias ^f   Buhl, Roland ^g   Dusser, Daniel ^h   Samara, Katerina ⁱ   Siafakas, Nikolaus ⁱ  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b HOSPITAL CLÍNIC   (Spain)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d Son Pisa Health Centre for the IB Salut (Balearic Goverment)   (Spain)

^e UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^f HANNOVER MEDICAL SCHOOL   (Germany)

^g UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^h UNIVERSITÉ PARIS DESCARTES   (France)

ⁱ UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Case finding; COPD; Diagnosis; Early disease; Treatment

Indexed keywords

ACETYLCYSTEINE; BUDESONIDE; CORTICOSTEROID; FLUTICASONE; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; IPRATROPIUM BROMIDE; PLACEBO; SALMETEROL; TIOTROPIUM BROMIDE;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CORTICOSTEROID THERAPY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE EXACERBATION; EARLY DIAGNOSIS; EARLY INTERVENTION; EXERCISE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SMOKING; SMOKING CESSATION; SPIROMETRY; ST GEORGE RESPIRATORY QUESTIONNAIRE; STANDARD; TIDAL VOLUME; TREATMENT PLANNING; VITAL CAPACITY;

BRONCHODILATOR AGENTS; EARLY DIAGNOSIS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SMOKING CESSATION; SPIROMETRY;

EID: 80052960996     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2010.12.015     Document Type: Review

References (71)

1. A. Anzueto, and M. Miravitlles Modifying the clinical course of COPD Hot Top Respir Med 3 7 2008 1 23
2. Health and Social Care Information Centre Statistical bulletin 2005/02/HSCIC. National quality and outcomes framework for England 2004/05 2005 Health and Social Care Information Centre London
3. A.S. Buist, M.A. McBurnie, W.M. Vollmer, S. Gillespie, P. Burney, and D.M. Mannino International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study Lancet 370 2007 741 750 (Pubitemid 47321907)
4. Global Initiative for Chronic Obstructive Lung Disease Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2009) 2009 Medical Communications Resources, Inc Gig Harbor, WA
5. Institute for Clinical Systems Improvement Health care guideline: diagnosis and management of chronic obstructive pulmonary disease (COPD) 2009 Institute for Clinical Systems Improvement Bloomington, MN
6. B.R. Celli, and W. MacNee Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper Eur Respir J 23 2004 932 946 (Pubitemid 38807371)
7. N. Tzanakis, U. Anagnostopoulou, V. Filaditaki, P. Christaki, and N. Siafakas Prevalence of COPD in Greece Chest 125 2004 892 900 (Pubitemid 38367279)
8. L. Shahab, M.J. Jarvis, J. Britton, and R. West Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample Thorax 61 2006 1043 1047 (Pubitemid 44852021)
9. M. Miravitlles, J.B. Soriano, F. Garcia-Rio, L. Munoz, E. Duran-Tauleria, and G. Sanchez Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities Thorax 64 2009 863 868
10. S.C. Hvidsten, L. Storesund, T. Wentzel-Larsen, A. Gulsvik, and S. Lehmann Prevalence and predictors of undiagnosed chronic obstructive pulmonary disease in a Norwegian adult general population Clin Respir J 4 2010 13 21
11. Y. Fukuchi, M. Nishimura, M. Ichinose, M. Adachi, A. Nagai, and T. Kuriyama COPD in Japan: the Nippon COPD Epidemiology study Respirology 9 2004 458 465 (Pubitemid 40179750)
12. M. Bednarek, J. Maciejewski, M. Wozniak, P. Kuca, and J. Zielinski Prevalence, severity and underdiagnosis of COPD in the primary care setting Thorax 63 2008 402 407 (Pubitemid 351692346)
13. V.S. Pena, M. Miravitlles, R. Gabriel, C.A. Jimenez-Ruiz, C. Villasante, and J.F. Masa Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study Chest 118 2000 981 989
14. M.V. Lopez Varela, A. Muino, R. Perez Padilla, J.R. Jardim, C. Talamo, and M. Montes de Oca [Treatment of chronic obstructive pulmonary disease in 5 Latin American cities: the PLATINO study] Arch Bronconeumol 44 2008 58 64 (Pubitemid 351670863)
15. D.M. Halpin, and M. Miravitlles Chronic obstructive pulmonary disease: the disease and its burden to society Proc Am Thorac Soc 3 2006 619 623 (Pubitemid 44411630)
16. M. Miravitlles, C. de la Roza, J. Morera, T. Montemayor, E. Gobartt, and A. Martin Chronic respiratory symptoms, spirometry and knowledge of COPD among general population Respir Med 100 2006 1973 1980 (Pubitemid 44490285)
17. M. Miravitlles, C. de la Roza, K. Naberan, M. Lamban, E. Gobartt, and A. Martin Use of spirometry and patterns of prescribing in COPD in primary care Respir Med 101 2007 1753 1760 (Pubitemid 46947875)
18. D.B. Coultas, D. Mapel, R. Gagnon, and E. Lydick The health impact of undiagnosed airflow obstruction in a national sample of United States adults Am J Respir Crit Care Med 164 2001 372 377 (Pubitemid 32778201)
19. R. Kohansal, P. Martinez-Camblor, A. Agusti, A.S. Buist, D.M. Mannino, and J.B. Soriano The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort Am J Respir Crit Care Med 180 2009 3 10
20. A. Domingo-Salvany, R. Lamarca, M. Ferrer, J. Garcia-Aymerich, J. Alonso, and M. Felez Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 166 2002 680 685 (Pubitemid 34971850)
21. J. Garcia-Aymerich, P. Lange, M. Benet, P. Schnohr, and J.M. Anto Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study Am J Respir Crit Care Med 175 2007 458 463 (Pubitemid 46354249)
22. M. Arne, C. Janson, S. Janson, G. Boman, U. Lindqvist, and C. Berne Physical activity and quality of life in subjects with chronic disease: chronic obstructive pulmonary disease compared with rheumatoid arthritis and diabetes mellitus Scand J Prim Health Care 27 2009 141 147
23. P.O. Bridevaux, M.W. Gerbase, N.M. Probst-Hensch, C. Schindler, J.M. Gaspoz, and T. Rochat Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD Thorax 63 2008 768 774
24. D. Ofir, P. Laveneziana, K.A. Webb, Y.M. Lam, and D.E. O'Donnell Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease Am J Respir Crit Care Med 177 2008 622 629 (Pubitemid 351442169)
25. T.A. Omachi, P.P. Katz, E.H. Yelin, S.E. Gregorich, C. Iribarren, and P.D. Blanc Depression and health-related quality of life in chronic obstructive pulmonary disease Am J Med 122 2009 778.e9-778.e15
26. M. Miravitlles, C. Murio, T. Guerrero, and R. Gisbert Costs of chronic bronchitis and COPD: a 1-year follow-up study Chest 123 2003 784 791 (Pubitemid 36315494)
27. R.W. Dal Negro, S. Tognella, R. Tosatto, M. Dionisi, P. Turco, and C.F. Donner Costs of chronic obstructive pulmonary disease (COPD) in Italy: the SIRIO study (social impact of respiratory integrated outcomes) Respir Med 102 2008 92 101 (Pubitemid 350161843)
28. D. Mannino, and N.L. Hudson The natural history of chronic obstructive pulmonary disease Hot Top Respir Med 4 11 2009 7 14
29. British Thoracic Society Spirometry in practice 2005 BTS COPD Consortium London
30. D. Price, A. Crockett, M. Arne, B. Garbe, R.C. Jones, and A. Kaplan Spirometry in primary care case-identification, diagnosis and management of COPD Prim Care Respir J 18 2009 216 223
31. J.B. Soriano, J. Zielinski, and D. Price Screening for and early detection of chronic obstructive pulmonary disease Lancet 374 2009 721 732
32. National Institute for Clinical Excellence Management of chronic obstructive pulmonary disease in adults in primary and secondary care. Clinical guideline 101 June 2010 National Institute for Clinical Excellence London
33. C.P. Van Schayck, J.M. Loozen, E. Wagena, R.P. Akkermans, and G.J. Wesseling Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study BMJ 324 2002 1370
34. F.J. Martinez, A.E. Raczek, F.D. Seifer, C.S. Conoscenti, T.G. Curtice, and T. D'Eletto Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS) COPD 5 2008 85 95 (Pubitemid 351549828)
35. D.B. Price, D.G. Tinkelman, R.J. Halbert, R.J. Nordyke, S. Isonaka, and D. Nonikov Symptom-based questionnaire for identifying COPD in smokers Respiration 73 2006 285 295 (Pubitemid 43739190)
36. D.B. Price, D.G. Tinkelman, R.J. Nordyke, S. Isonaka, and R.J. Halbert Scoring system and clinical application of COPD diagnostic questionnaires Chest 129 2006 1531 1539 (Pubitemid 43894982)
37. D. Kotz, P. Nelemans, C.P. van Schayck, and G.J. Wesseling External validation of a COPD diagnostic questionnaire Eur Respir J 31 2008 298 303
38. J. de Miguel Diez, J.L. Izquierdo Alonso, J. Molina Paris, J.M. Rodriguez Gonzalez-Moro, P. de Lucas Ramos, and G. Gaspar Alonso-Vega [Reliability of chronic obstructive pulmonary disease diagnosis by primary care physicians and pneumologists in Spain. Predictive factors] Arch Bronconeumol 39 2003 203 208 (Pubitemid 36736199)
39. K. Naberan, C. De la Roza, M. Lamban, E. Gobartt, A. Martin, and M. Miravitlles [Use of spirometry in the diagnosis and treatment of chronic obstructive pulmonary disease in primary care] Arch Bronconeumol 42 2006 638 644 (Pubitemid 46132368)
40. L. Sichletidis, D. Chloros, D. Spyratos, N. Chatzidimitriou, P. Chatziiliadis, and N. Protopappas The validity of the diagnosis of chronic obstructive pulmonary disease in general practice Prim Care Respir J 16 2007 82 88 (Pubitemid 46698771)
41. C. Pellicer Ciscar, J.J. Soler Cataluna, A.L. Andreu Rodriguez, and J. Bueso Fabra [Diagnosis of COPD in hospitalised patients] Arch Bronconeumol 46 2010 64 69
42. R.J. Buckingham, D. Lowe, N.A. Pursey, C.M. Roberts, and R.A. Stone Report 5 of the national chronic obstructive pulmonary disease audit 2008: survey of COPD care within UK general practices 2008 Royal College of Physicians of London London
43. J. Zielinski, and M. Bednarek Early detection of COPD in a high-risk population using spirometric screening Chest 119 2001 731 736 (Pubitemid 32197641)
44. K. Lin, B. Watkins, T. Johnson, J.A. Rodriguez, and M.B. Barton Screening for chronic obstructive pulmonary disease using spirometry: summary of the evidence for the U.S. Preventive Services Task Force Ann Intern Med 148 2008 535 543 (Pubitemid 351665424)
45. J. Buffels, J. Degryse, J. Heyrman, and M. Decramer Office spirometry significantly improves early detection of COPD in general practice: the DIDASCO study Chest 125 2004 1394 1399 (Pubitemid 38501355)
46. D. Castillo, R. Guayta, J. Giner, F. Burgos, C. Capdevila, and J.B. Soriano COPD case finding by spirometry in high-risk customers of urban community pharmacies: a pilot study Respir Med 103 2009 839 845
47. L. Tuomisto, V. Jarvinen, J. Laitinen, M. Erhola, M. Kaila, and P. Brander Asthma programme in Finland: the quality of primary care spirometry is good Prim Care Respir J 17 2008 226 231
48. C.E. Bolton, A.A. Ionescu, P.H. Edwards, T.A. Faulkner, S.M. Edwards, and D.J. Shale Attaining a correct diagnosis of COPD in general practice Respir Med 99 2005 493 500 (Pubitemid 40347834)
49. T.A. Lee, B. Bartle, and K.B. Weiss Spirometry use in clinical practice following diagnosis of COPD Chest 129 2006 1509 1515 (Pubitemid 43894979)
50. J. Hueto, P. Cebollero, I. Pascal, J.A. Cascante, V.M. Eguia, and F. Teruel [Spirometry in primary care in Navarre, Spain] Arch Bronconeumol 42 2006 326 331 (Pubitemid 44213734)
51. M.L. Levy, P.H. Quanjer, R. Booker, B.G. Cooper, S. Holmes, and I. Small Diagnostic spirometry in primary care: proposed standards for general practice compliant with American Thoracic Society and European Respiratory Society recommendations: a General Practice Airways Group (GPIAG) document, in association with the Association for Respiratory Technology & Physiology (ARTP) and Education for Health Prim Care Respir J 18 2009 130 147
52. 1/FVC ratio in the elderly Prim Care Respir J 15 2006 294 298 (Pubitemid 44485618)
53. 1/FVC and FVC in the spirometric detection of airway obstruction and restriction Chest 127 2005 1560 1564 (Pubitemid 46218779)
54. G.T. Ferguson The importance of early diagnosis in chronic obstructive pulmonary disease Hot Top Respir Med 4 11 2009 15 21
55. A. Qaseem, V. Snow, P. Shekelle, K. Sherif, T.J. Wilt, and S. Weinberger Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians Ann Intern Med 147 2007 633 638 (Pubitemid 351664484)
56. C.R. Jenkins, P.W. Jones, P.M. Calverley, B. Celli, J.A. Anderson, and G.T. Ferguson Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study Respir Res 10 2009 59
57. M. Decramer, B. Celli, S. Kesten, T. Lystig, S. Mehra, and D.P. Tashkin Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial Lancet 374 2009 1171 1178
58. M. Decramer, and C.B. Cooper Treatment of COPD: the sooner the better? Thorax 65 2010 837 841
59. 1. The Lung Health Study JAMA 272 1994 1497 1505
60. P.D. Scanlon, J.E. Connett, L.A. Waller, M.D. Altose, W.C. Bailey, and A.S. Buist Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study Am J Respir Crit Care Med 161 2000 381 390 (Pubitemid 30129442)
61. R.A. Pauwels, C.G. Lofdahl, L.A. Laitinen, J.P. Schouten, D.S. Postma, and N.B. Pride Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease N Engl J Med 340 1999 1948 1953 (Pubitemid 29288270)
62. J. Vestbo, T. Sorensen, P. Lange, A. Brix, P. Torre, and K. Viskum Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial Lancet 353 1999 1819 1823 (Pubitemid 29251012)
63. Lung Health Study Research Group Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease N Engl J Med 343 2000 1902 1909
64. P.W. Jones, L.R. Willits, P.S. Burge, and P.M. Calverley Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations Eur Respir J 21 2003 68 73 (Pubitemid 36150303)
65. P.S. Burge, P.M. Calverley, P.W. Jones, S. Spencer, J.A. Anderson, and T.K. Maslen Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial BMJ 320 2000 1297 1303 (Pubitemid 30245717)
66. M. Decramer, M. Rutten-van Molken, P.N. Dekhuijzen, T. Troosters, C. van Herwaarden, and R. Pellegrino Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial Lancet 365 2005 1552 1560 (Pubitemid 40615404)
67. D. Dusser, M.L. Bravo, and P. Iacono The effect of tiotropium on exacerbations and airflow in patients with COPD Eur Respir J 27 2006 547 555 (Pubitemid 43372529)
68. B.R. Celli, N.E. Thomas, J.A. Anderson, G.T. Ferguson, C.R. Jenkins, and P.W. Jones Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study Am J Respir Crit Care Med 178 2008 332 338
69. D.P. Tashkin, B. Celli, S. Senn, D. Burkhart, S. Kesten, and S. Menjoge 4-year trial of tiotropium in chronic obstructive pulmonary disease N Engl J Med 359 2008 1543 1554
70. T. Troosters, B. Celli, T. Lystig, S. Kesten, S. Mehra, and D.P. Tashkin Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial Eur Respir J 2010 [Epub ahead of print]
71. D.E. O'Donnell, P. Laveneziana, J. Ora, K.A. Webb, Y.M. Lam, and D. Ofir Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD Thorax 64 2009 216 223